LMR Partners’s XBiotech XBIT Stock Holding History

LMR Partners’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-34,326	Closed	-$154K	–	524
2018 Q2	$154K	Buy	+34,326	New	+$155K	0.01%	436
2017 Q3	–	Sell	-26,184	Closed	-$123K	–	567
2017 Q2	$123K	Buy	+26,184	New	+$251K	0.01%	559

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LMR Partners's XBIT Position: Q3 2018 in Review

LMR Partners sold out of XBiotech (XBIT) in Q3 2018, closing a stake of 34,326 shares — an estimated $154K sold.

LMR Partners first reported a position in XBIT in Q2 2017 and held it in 2 quarters. The position peaked at $154K in Q2 2018. 24 funds tracked by Wall St. Rank hold XBIT as of Q3 2018.

LMR Partners reported no remaining XBiotech position as of Q3 2018 after selling out during the quarter.
LMR Partners sold 34,326 XBiotech shares in Q3 2018, an estimated $154K.
LMR Partners first reported a position in XBiotech in Q2 2017 and held it in 2 quarters.
LMR Partners's XBiotech position peaked at $154K in Q2 2018.
24 funds tracked by Wall St. Rank held XBiotech as of Q3 2018.

Based on LMR Partners's 13F filing for Q3 2018, filed 14 Nov 2018.